NEW YORK, June 15 (GenomeWeb News) - Aria Biosystems, a biomolecular sensor startup, has raised $5.5 million in an initial round of venture capital financing, the company said today.
The Menlo Park, Calif. company said it will use the proceeds of this initial round to complete development of a first product and to further development of subsequent products.
Aria's technology is based on fiber optics and adopted from the telecommunications industry. The disposable sensors are self-calibrating, and can can measure concentrations of analytes and binding kinetics in real time, without labeling, according to the company.
Alloy Ventures and Latterell Venture Partners co-led the round, and were joined by Agilent Ventures and Versant Ventures.
In conjunction with the financing, Aria announced that Craig Taylor, general partner of Alloy Ventures, James Woody, a venture partner of Latterell Venture Partners; and Deborah Neff, President and CEO of Predicant Biosciences, would be joining the company's board, along with Winnie Wan, the company's CEO and co-founder.
Other founding executives of Aria include Hong Tan, president and chief technical officer, Dave Hoyt, chief financial officer, and Bob Zuk, vice president of development.